PAREXEL and SHYFT Analytics Partner to Deliver Real-World Data Studies

Published on: 

Applied Clinical Trials

SHYFT Analytics and PAREXEL International, a provider of biopharmaceutical services, announced that the companies have entered into a partnership that establishes SHYFT’s technology as a part of PAREXEL’s foundation for Real-World Evidence generation and outcomes research for biopharmaceutical and medical device clients. The partnership aims to optimize the design and execution of ongoing and retrospective clinical studies.

Read the full release here.